Di Maio R, Cerecetto H, Seoane G, Ochoa C, Arán V J, Pérez E, Gómez Barrio A, Muelas S
Cátedra de Química Orgánica, Facultad de Química y Ciencias, Universidad de la República, Montevideo, Uruguay.
Arzneimittelforschung. 1999 Sep;49(9):759-63. doi: 10.1055/s-0031-1300498.
In a search for antichagasic drugs, 14 new 4-(nitroarylidene)-1,2,6-thiadiazin-3,5-dione 1,1-dioxide derivatives were synthesized and tested in vitro against the epimastigote form of Trypanosoma cruzi and some of them showed important antiprotozoan activity. Attempts to synthesize new 4-(nitroarylidene)-3,5-diamino-1,2,6-thiadiazine 1,1-dioxides were unsuccessful. The antichagasic properties of nitroarylidene-malononitrile and nitroarylidene-cyanoacetamide derivatives, thus obtained, were also tested. The cytotoxic properties against Vero cells of compounds which showed remarkable in vitro antichagasic activity were evaluated. All compounds tested exhibited high toxicity percentages at 100 micrograms/ml. However, compound 3c showed in vitro antichagasic and cytotoxic properties such as nifurtimox at the dose of 10 micrograms/ml.
为了寻找抗恰加斯病药物,合成了14种新的4-(硝基亚苄基)-1,2,6-噻二嗪-3,5-二酮1,1-二氧化物衍生物,并对其进行了体外抗克氏锥虫前鞭毛体形式的测试,其中一些显示出重要的抗原生动物活性。合成新的4-(硝基亚苄基)-3,5-二氨基-1,2,6-噻二嗪1,1-二氧化物的尝试未成功。还测试了由此获得的硝基亚苄基丙二腈和硝基亚苄基氰基乙酰胺衍生物的抗恰加斯病特性。评估了具有显著体外抗恰加斯病活性的化合物对Vero细胞的细胞毒性特性。所有测试化合物在100微克/毫升时均表现出高毒性百分比。然而,化合物3c在10微克/毫升的剂量下显示出与硝呋替莫相似的体外抗恰加斯病和细胞毒性特性。